Cargando…
Reversible Cerebral Vasoconstriction Syndrome Exacerbation After Calcitonin Gene–Related Peptide Inhibitor Administration
Background: Reversible cerebral vasoconstriction syndrome (RCVS) is a non-inflammatory vasculopathy. While most patients have good clinical outcomes, RCVS can be associated with severe brain injury from ischemic stroke, subarachnoid, and intracerebral hemorrhage. Purpose: A number of vasoactive medi...
Autores principales: | Zhao, Megan, Kaiser, Eric, Cucchiara, Brett, Zuflacht, Jonah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494831/ https://www.ncbi.nlm.nih.gov/pubmed/37701251 http://dx.doi.org/10.1177/19418744231173832 |
Ejemplares similares
-
Migration of Vasoconstriction in Reversible Cerebral Vasoconstriction Syndrome
por: Hashimoto, Tetsuya, et al.
Publicado: (2022) -
Pathophysiology of reversible cerebral vasoconstriction syndrome
por: Chen, Shih-Pin, et al.
Publicado: (2022) -
Reversible cerebral vasoconstriction syndrome: case report
por: Öz, Oğuzhan, et al.
Publicado: (2009) -
Autonomic dysfunction in reversible cerebral vasoconstriction syndromes
por: Chen, Shih-Pin, et al.
Publicado: (2013) -
Intraventricular hemorrhage in reversible cerebral vasoconstriction syndrome
por: Wilson, Duncan, et al.
Publicado: (2014)